Search Results 151-160 of 18753 for amyloidosis

  1. Michelle L. Mauermann, M.D. - Mayo Clinic Faculty Profiles

    Hereditary amyloidosis. Hereditary transthyretin amyloidosis causes a fatal multisystem disorder that includes the peripheral nerves, autonomic nervous system, ...

  2. Curriculum - Advanced Hematology Fellowship (Minnesota) - Mayo Clinic College of Medicine & Science

    New for 2025: Amyloidosis track. The Advanced Hematology Fellowship is offering an additional one-year amyloidosis track for the academic year beginning July 1, ...

  3. CLEOPATTRA: A Research Study To Look At The Effects Of Treatment With A Medicine Called Coramitug (NNC6019-0001) In People With Heart Failure Due To Transthyretin Amyloid (ATTR) Amyloidosis - Mayo Clinic

    * Current diagnosis or history of amyloid light chain, other non-ATTR amyloidosis, known leptomeningeal amyloidosis, or multiple myeloma. * HF not primarily ...

  4. Bone Marrow Transplant Program - Experience in treating leukemia and other complex conditions - Mayo Clinic

    ... amyloidosis and POEMS syndrome. Mayo Clinic doctors will work with you to review all of your treatment options and choose the treatment that best suits your ...

  5. A Study to Evaluate the Effectiveness and Safety of CAEL-101 in Patients with Mayo Stage IIIa AL Amyloidosis

    The purpose of this study is to determine if CAEL-101 improves the overall survival in patients with cardiac AL Amyloidosis. Participation eligibility.

  6. Incredible Journey: Surviving an Incurable Disease - Mayo Clinic News Network

    He performed a thorough cardiac evaluation and examined all her test results. Dr. Steidley then gave her the final diagnosis - primary cardiac amyloidosis - an ...

  7. Jose N. Nativi Nicolau, M.D. - Doctors and Medical Staff - Mayo Clinic

    ... amyloidosis. He is an investigator in multiple international clinical trials for amyloidosis, including ATTR-ACT for tafamidis, expanded access for ...

  8. A Phase 1b/2 Study Of CAR T Cell Therapy Targeting CD19 And BCMA In Participants With Relapsed Or Refractory AL Amyloidosis. - Mayo Clinic

    A Phase 1b/2 Study Of CAR T Cell Therapy Targeting CD19 And BCMA In Participants With Relapsed Or Refractory AL Amyloidosis. · More about research at Mayo Clinic.

  9. A Study to Evaluate the Effectiveness and Safety of Birtamimab in Mayo Stage IV Patients With AL Amyloidosis

    A Study to Evaluate the Effectiveness and Safety of Birtamimab in Mayo Stage IV Patients With AL Amyloidosis · Overview · Participation eligibility · Participating ...

  10. CLEOPATTRA: A Research Study To Look At The Effects Of Treatment With A Medicine Called Coramitug (NNC6019-0001) In People With Heart Failure Due To Transthyretin Amyloid (ATTR) Amyloidosis - Mayo Clinic

    Current diagnosis or history of amyloid light chain, other non-ATTR amyloidosis, known leptomeningeal amyloidosis, or multiple myeloma. HF not primarily ...